Association of Crohn's Disease with Aryl Hydrocarbon Receptor Gene Polymorphisms in Patients from Southeast China

Chao-Qun Wu1, Qian-Ru Lin1, Shi-Jie Ying1

  • 1Department of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University , Wenzhou , Zhejiang Province , China.

Insights

The aryl hydrocarbon receptor (AhR) gene variant rs2158041 may be linked to Crohn's disease (CD) susceptibility in Southeast China. This specific AhR polymorphism was less common in CD patients, particularly those with ileal or stricture CD.

Area of Science:

  • Immunology
  • Genetics
  • Gastroenterology

Background:

  • The aryl hydrocarbon receptor (AhR) is crucial for immune system regulation.
  • Crohn's disease (CD) involves complex genetic and immune factors.
  • Understanding genetic associations can elucidate CD pathogenesis.

Purpose of the Study:

  • To investigate the association between specific aryl hydrocarbon receptor (AhR) gene polymorphisms and Crohn's disease (CD) in a Southeast Chinese population.
  • To identify potential genetic risk factors for CD development and subtypes.

Main Methods:

  • Utilized an improved multiple ligase detection reaction technique.
  • Genotyped three AhR polymorphisms (rs2158041, rs2066853, rs10249788) in 310 CD patients and 573 controls.
  • Performed association and haplotype analyses.

Main Results:

  • The variant allele (T) and genotype (CT+TT) of rs2158041 were significantly less frequent in CD patients compared to controls (p < 0.05).
  • This association remained significant for ileal CD and stricture CD subtypes (p < 0.0083).
  • No significant differences were found for rs2066853 and rs10249788 polymorphisms or their linkage disequilibrium, except for the rs2158041-rs2066853 (TG) haplotype, which was less frequent in CD patients (p < 0.05).

Conclusions:

  • The AhR gene polymorphism rs2158041 may represent a susceptible locus for Crohn's disease.
  • This association is particularly relevant for ileal CD and stricture CD subtypes.
  • Further research into AhR's role in CD pathogenesis is warranted.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...